Patents by Inventor Victor M. Guzman

Victor M. Guzman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPLEMENT FACTOR Bb ANTIBODIES
    Publication number: 20230124150
    Abstract: The present disclosure relates to antibodies and polynucleotides encoding the same, which may be used to prevent, control, or reduce the activity of the complement pathway. In addition, the disclosure is directed to compositions and methods for diagnosing and treating diseases mediated by or involving complement Factor Bb. Specifically, the disclosure is related to anti-complement Factor Bb antibodies.
    Type: Application
    Filed: August 12, 2022
    Publication date: April 20, 2023
    Inventors: Yanbin LIANG, Chen LI, Iris LEE, Victor M. GUZMAN
  • COMPLEMENT FACTOR Bb ANTIBODIES
    Publication number: 20200317762
    Abstract: The present disclosure relates to antibodies and polynucleotides encoding the same, which may be used to prevent, control, or reduce the activity of the complement pathway. In addition, the disclosure is directed to compositions and methods for diagnosing and treating diseases mediated by or involving complement Factor Bb. Specifically, the disclosure is related to anti-complement Factor Bb antibodies.
    Type: Application
    Filed: March 27, 2020
    Publication date: October 8, 2020
    Inventors: Yanbin Liang, Chen Li, Iris Lee, Victor M. Guzman
  • Nucleic acids encoding anti-complement Factor Bb antibodies
    Patent number: 10604563
    Abstract: The present disclosure relates to antibodies and polynucleotides encoding the same, which may be used to prevent, control, or reduce the activity of the complement pathway. In addition, the disclosure is directed to compositions and methods for diagnosing and treating diseases mediated by or involving complement Factor Bb. Specifically, the disclosure is related to anti-complement Factor Bb antibodies.
    Type: Grant
    Filed: September 26, 2018
    Date of Patent: March 31, 2020
    Assignee: Allergan, Inc.
    Inventors: Yanbin Liang, Chen Li, Iris Lee, Victor M. Guzman
  • COMPLEMENT FACTOR Bb ANTIBODIES
    Publication number: 20190071492
    Abstract: The present disclosure relates to antibodies and polynucleotides encoding the same, which may be used to prevent, control, or reduce the activity of the complement pathway. In addition, the disclosure is directed to compositions and methods for diagnosing and treating diseases mediated by or involving complement Factor Bb. Specifically, the disclosure is related to anti-complement Factor Bb antibodies.
    Type: Application
    Filed: September 26, 2018
    Publication date: March 7, 2019
    Inventors: Yanbin Liang, Chen Li, Iris Lee, Victor M. Guzman
  • Methods of treating a complement associated eye condition by administering complement factor Bb antibodies
    Patent number: 10093724
    Abstract: The present disclosure relates to antibodies and polynucleotides encoding the same, which may be used to prevent, control, or reduce the activity of the complement pathway. In addition, the disclosure is directed to compositions and methods for diagnosing and treating diseases mediated by or involving complement Factor Bb. Specifically, the disclosure is related to anti-complement Factor Bb antibodies.
    Type: Grant
    Filed: October 23, 2017
    Date of Patent: October 9, 2018
    Assignee: Allergan, Inc.
    Inventors: Yanbin Liang, Chen Li, Iris Lee, Victor M. Guzman
  • COMPLEMENT FACTOR Bb ANTIBODIES
    Publication number: 20180057576
    Abstract: The present disclosure relates to antibodies and polynucleotides encoding the same, which may be used to prevent, control, or reduce the activity of the complement pathway. In addition, the disclosure is directed to compositions and methods for diagnosing and treating diseases mediated by or involving complement Factor Bb. Specifically, the disclosure is related to anti-complement Factor Bb antibodies.
    Type: Application
    Filed: October 23, 2017
    Publication date: March 1, 2018
    Inventors: Yanbin Liang, Chen Li, Iris Lee, Victor M. Guzman
  • Complement factor Bb antibodies
    Patent number: 9796776
    Abstract: The present disclosure relates to antibodies and polynucleotides encoding the same, which may be used to prevent, control, or reduce the activity of the complement pathway. In addition, the disclosure is directed to compositions and methods for diagnosing and treating diseases mediated by or involving complement Factor Bb. Specifically, the disclosure is related to anti-complement Factor Bb antibodies.
    Type: Grant
    Filed: February 25, 2015
    Date of Patent: October 24, 2017
    Assignee: Allergan, Inc.
    Inventors: Yanbin Liang, Chen Li, Iris Lee, Victor M. Guzman
  • COMPLEMENT FACTOR Bb ANTIBODIES
    Publication number: 20150239987
    Abstract: The present disclosure relates to antibodies and polynucleotides encoding the same, which may be used to prevent, control, or reduce the activity of the complement pathway. In addition, the disclosure is directed to compositions and methods for diagnosing and treating diseases mediated by or involving complement Factor Bb. Specifically, the disclosure is related to anti-complement Factor Bb antibodies.
    Type: Application
    Filed: February 25, 2015
    Publication date: August 27, 2015
    Inventors: Yanbin Liang, Chen Li, Iris Lee, Victor M. Guzman